599 related articles for article (PubMed ID: 15712178)
1. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
4. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
5. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
6. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
7. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
8. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.
Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD
Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118
[TBL] [Abstract][Full Text] [Related]
9. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
10. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
[TBL] [Abstract][Full Text] [Related]
11. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
12. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.
Leroy X; Moukassa D; Copin MC; Saint F; Mazeman E; Gosselin B
Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas.
Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H
Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167
[TBL] [Abstract][Full Text] [Related]
14. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases.
Din NU; Fatima S; Ahmad Z
Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630
[TBL] [Abstract][Full Text] [Related]
16. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
17. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
19. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
20. Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes.
Mai KT; Burns BF
Acta Histochem; 2000 Feb; 102(1):103-13. PubMed ID: 10726169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
